nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—HTR6—Alzheimer's disease	0.261	0.64	CbGaD
Olanzapine—HTR3A—Memantine—Alzheimer's disease	0.137	0.341	CbGbCtD
Olanzapine—HTR2A—Alzheimer's disease	0.0768	0.188	CbGaD
Olanzapine—CYP2D6—Alzheimer's disease	0.0702	0.172	CbGaD
Olanzapine—HTR2A—Donepezil—Alzheimer's disease	0.0643	0.16	CbGbCtD
Olanzapine—DRD2—Memantine—Alzheimer's disease	0.0514	0.128	CbGbCtD
Olanzapine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0268	0.0665	CbGbCtD
Olanzapine—CYP2C19—Memantine—Alzheimer's disease	0.0244	0.0607	CbGbCtD
Olanzapine—CYP2C9—Donepezil—Alzheimer's disease	0.0234	0.0582	CbGbCtD
Olanzapine—CYP2D6—Donepezil—Alzheimer's disease	0.0214	0.0532	CbGbCtD
Olanzapine—CYP3A4—Rivastigmine—Alzheimer's disease	0.017	0.0423	CbGbCtD
Olanzapine—CYP2D6—Galantamine—Alzheimer's disease	0.0138	0.0343	CbGbCtD
Olanzapine—CYP3A4—Donepezil—Alzheimer's disease	0.0136	0.0338	CbGbCtD
Olanzapine—CYP3A4—Galantamine—Alzheimer's disease	0.00877	0.0218	CbGbCtD
Olanzapine—HTR2C—choroid plexus—Alzheimer's disease	0.00557	0.0694	CbGeAlD
Olanzapine—DRD3—telencephalic ventricle—Alzheimer's disease	0.00294	0.0366	CbGeAlD
Olanzapine—HTR2A—choroid plexus—Alzheimer's disease	0.0028	0.0348	CbGeAlD
Olanzapine—HTR7—locus ceruleus—Alzheimer's disease	0.00277	0.0345	CbGeAlD
Olanzapine—HTR5A—forebrain—Alzheimer's disease	0.0022	0.0274	CbGeAlD
Olanzapine—DRD1—telencephalic ventricle—Alzheimer's disease	0.0021	0.0262	CbGeAlD
Olanzapine—HTR2A—locus ceruleus—Alzheimer's disease	0.00173	0.0215	CbGeAlD
Olanzapine—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0017	0.0212	CbGeAlD
Olanzapine—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00165	0.0205	CbGeAlD
Olanzapine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00163	0.0203	CbGeAlD
Olanzapine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00141	0.0175	CbGeAlD
Olanzapine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00137	0.0171	CbGeAlD
Olanzapine—HTR7—telencephalic ventricle—Alzheimer's disease	0.00131	0.0164	CbGeAlD
Olanzapine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00124	0.0155	CbGeAlD
Olanzapine—HTR5A—nervous system—Alzheimer's disease	0.0012	0.0149	CbGeAlD
Olanzapine—HTR5A—central nervous system—Alzheimer's disease	0.00115	0.0143	CbGeAlD
Olanzapine—HTR1E—forebrain—Alzheimer's disease	0.00094	0.0117	CbGeAlD
Olanzapine—HTR5A—brain—Alzheimer's disease	0.000914	0.0114	CbGeAlD
Olanzapine—HTR1E—telencephalon—Alzheimer's disease	0.000865	0.0108	CbGeAlD
Olanzapine—HTR1B—blood vessel—Alzheimer's disease	0.000843	0.0105	CbGeAlD
Olanzapine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000819	0.0102	CbGeAlD
Olanzapine—HTR1D—blood vessel—Alzheimer's disease	0.000816	0.0102	CbGeAlD
Olanzapine—HTR6—forebrain—Alzheimer's disease	0.000738	0.00919	CbGeAlD
Olanzapine—DRD5—forebrain—Alzheimer's disease	0.000718	0.00895	CbGeAlD
Olanzapine—HTR6—telencephalon—Alzheimer's disease	0.000679	0.00845	CbGeAlD
Olanzapine—DRD5—telencephalon—Alzheimer's disease	0.000661	0.00823	CbGeAlD
Olanzapine—HTR7—blood vessel—Alzheimer's disease	0.00065	0.0081	CbGeAlD
Olanzapine—H1F0—embryo—Alzheimer's disease	0.000629	0.00783	CbGeAlD
Olanzapine—H1F0—forebrain—Alzheimer's disease	0.000556	0.00692	CbGeAlD
Olanzapine—DRD1—forebrain—Alzheimer's disease	0.000549	0.00684	CbGeAlD
Olanzapine—HTR3A—forebrain—Alzheimer's disease	0.00053	0.0066	CbGeAlD
Olanzapine—Amoxapine—HTR6—Alzheimer's disease	0.000513	0.183	CrCbGaD
Olanzapine—H1F0—telencephalon—Alzheimer's disease	0.000511	0.00637	CbGeAlD
Olanzapine—HTR1E—nervous system—Alzheimer's disease	0.000511	0.00636	CbGeAlD
Olanzapine—DRD1—telencephalon—Alzheimer's disease	0.000505	0.00629	CbGeAlD
Olanzapine—HTR1E—central nervous system—Alzheimer's disease	0.000492	0.00612	CbGeAlD
Olanzapine—HTR3A—telencephalon—Alzheimer's disease	0.000488	0.00607	CbGeAlD
Olanzapine—DRD4—brain—Alzheimer's disease	0.000453	0.00564	CbGeAlD
Olanzapine—CHRM4—nervous system—Alzheimer's disease	0.000448	0.00557	CbGeAlD
Olanzapine—HTR1B—forebrain—Alzheimer's disease	0.000445	0.00554	CbGeAlD
Olanzapine—CHRM2—forebrain—Alzheimer's disease	0.000442	0.00551	CbGeAlD
Olanzapine—CHRM4—central nervous system—Alzheimer's disease	0.000431	0.00537	CbGeAlD
Olanzapine—HTR1D—forebrain—Alzheimer's disease	0.000431	0.00536	CbGeAlD
Olanzapine—HTR2C—forebrain—Alzheimer's disease	0.000426	0.00531	CbGeAlD
Olanzapine—DRD3—nervous system—Alzheimer's disease	0.000416	0.00518	CbGeAlD
Olanzapine—FMO3—nervous system—Alzheimer's disease	0.000412	0.00512	CbGeAlD
Olanzapine—HTR1B—telencephalon—Alzheimer's disease	0.000409	0.00509	CbGeAlD
Olanzapine—CHRM2—telencephalon—Alzheimer's disease	0.000407	0.00507	CbGeAlD
Olanzapine—HTR2A—blood vessel—Alzheimer's disease	0.000405	0.00505	CbGeAlD
Olanzapine—CHRM1—forebrain—Alzheimer's disease	0.000403	0.00501	CbGeAlD
Olanzapine—Loxapine—HTR6—Alzheimer's disease	0.000401	0.143	CrCbGaD
Olanzapine—DRD3—central nervous system—Alzheimer's disease	0.000401	0.00499	CbGeAlD
Olanzapine—HTR6—nervous system—Alzheimer's disease	0.000401	0.00499	CbGeAlD
Olanzapine—HTR2B—forebrain—Alzheimer's disease	0.000401	0.00499	CbGeAlD
Olanzapine—FMO3—central nervous system—Alzheimer's disease	0.000396	0.00493	CbGeAlD
Olanzapine—HTR1D—telencephalon—Alzheimer's disease	0.000396	0.00493	CbGeAlD
Olanzapine—HTR2C—telencephalon—Alzheimer's disease	0.000392	0.00488	CbGeAlD
Olanzapine—Quetiapine—HTR6—Alzheimer's disease	0.000391	0.139	CrCbGaD
Olanzapine—HTR1E—brain—Alzheimer's disease	0.00039	0.00486	CbGeAlD
Olanzapine—DRD5—nervous system—Alzheimer's disease	0.00039	0.00486	CbGeAlD
Olanzapine—HTR6—central nervous system—Alzheimer's disease	0.000386	0.0048	CbGeAlD
Olanzapine—DRD5—central nervous system—Alzheimer's disease	0.000376	0.00468	CbGeAlD
Olanzapine—CHRM1—telencephalon—Alzheimer's disease	0.00037	0.00461	CbGeAlD
Olanzapine—HTR2B—telencephalon—Alzheimer's disease	0.000368	0.00459	CbGeAlD
Olanzapine—HRH2—nervous system—Alzheimer's disease	0.000366	0.00456	CbGeAlD
Olanzapine—CHRM3—forebrain—Alzheimer's disease	0.00036	0.00449	CbGeAlD
Olanzapine—HTR1A—forebrain—Alzheimer's disease	0.000359	0.00447	CbGeAlD
Olanzapine—HRH2—central nervous system—Alzheimer's disease	0.000353	0.00439	CbGeAlD
Olanzapine—CHRM5—nervous system—Alzheimer's disease	0.00035	0.00436	CbGeAlD
Olanzapine—HTR7—forebrain—Alzheimer's disease	0.000343	0.00427	CbGeAlD
Olanzapine—CHRM4—brain—Alzheimer's disease	0.000342	0.00426	CbGeAlD
Olanzapine—CHRM5—central nervous system—Alzheimer's disease	0.000337	0.00419	CbGeAlD
Olanzapine—Clozapine—HTR6—Alzheimer's disease	0.000336	0.12	CrCbGaD
Olanzapine—CHRM3—telencephalon—Alzheimer's disease	0.000331	0.00413	CbGeAlD
Olanzapine—ADRA1A—forebrain—Alzheimer's disease	0.000331	0.00412	CbGeAlD
Olanzapine—HTR1A—telencephalon—Alzheimer's disease	0.00033	0.00411	CbGeAlD
Olanzapine—DRD2—forebrain—Alzheimer's disease	0.000324	0.00404	CbGeAlD
Olanzapine—ADRA1B—nervous system—Alzheimer's disease	0.00032	0.00398	CbGeAlD
Olanzapine—DRD3—brain—Alzheimer's disease	0.000318	0.00396	CbGeAlD
Olanzapine—HTR7—telencephalon—Alzheimer's disease	0.000315	0.00393	CbGeAlD
Olanzapine—FMO3—brain—Alzheimer's disease	0.000315	0.00392	CbGeAlD
Olanzapine—ADRA1B—central nervous system—Alzheimer's disease	0.000308	0.00383	CbGeAlD
Olanzapine—HTR6—brain—Alzheimer's disease	0.000306	0.00381	CbGeAlD
Olanzapine—ADRA1A—telencephalon—Alzheimer's disease	0.000304	0.00379	CbGeAlD
Olanzapine—H1F0—nervous system—Alzheimer's disease	0.000302	0.00376	CbGeAlD
Olanzapine—DRD2—telencephalon—Alzheimer's disease	0.000298	0.00371	CbGeAlD
Olanzapine—DRD5—brain—Alzheimer's disease	0.000298	0.00371	CbGeAlD
Olanzapine—DRD1—nervous system—Alzheimer's disease	0.000298	0.00371	CbGeAlD
Olanzapine—H1F0—central nervous system—Alzheimer's disease	0.000291	0.00362	CbGeAlD
Olanzapine—ADRA2C—telencephalon—Alzheimer's disease	0.00029	0.00361	CbGeAlD
Olanzapine—HTR3A—nervous system—Alzheimer's disease	0.000288	0.00358	CbGeAlD
Olanzapine—DRD1—central nervous system—Alzheimer's disease	0.000287	0.00357	CbGeAlD
Olanzapine—H1F0—cerebellum—Alzheimer's disease	0.000284	0.00354	CbGeAlD
Olanzapine—HRH2—brain—Alzheimer's disease	0.00028	0.00349	CbGeAlD
Olanzapine—HTR3A—central nervous system—Alzheimer's disease	0.000277	0.00345	CbGeAlD
Olanzapine—CHRM5—brain—Alzheimer's disease	0.000267	0.00333	CbGeAlD
Olanzapine—ABCB1—blood vessel—Alzheimer's disease	0.000266	0.00331	CbGeAlD
Olanzapine—ORM1—nervous system—Alzheimer's disease	0.000258	0.00321	CbGeAlD
Olanzapine—HRH1—forebrain—Alzheimer's disease	0.000256	0.00319	CbGeAlD
Olanzapine—ADRA2A—forebrain—Alzheimer's disease	0.000252	0.00313	CbGeAlD
Olanzapine—ORM1—central nervous system—Alzheimer's disease	0.000248	0.00309	CbGeAlD
Olanzapine—ADRA1B—brain—Alzheimer's disease	0.000244	0.00304	CbGeAlD
Olanzapine—HTR2A—embryo—Alzheimer's disease	0.000242	0.00301	CbGeAlD
Olanzapine—HTR1B—nervous system—Alzheimer's disease	0.000241	0.00301	CbGeAlD
Olanzapine—CHRM2—nervous system—Alzheimer's disease	0.00024	0.00299	CbGeAlD
Olanzapine—HRH1—telencephalon—Alzheimer's disease	0.000236	0.00293	CbGeAlD
Olanzapine—HTR1D—nervous system—Alzheimer's disease	0.000234	0.00291	CbGeAlD
Olanzapine—HTR1B—central nervous system—Alzheimer's disease	0.000232	0.00289	CbGeAlD
Olanzapine—HTR2C—nervous system—Alzheimer's disease	0.000232	0.00288	CbGeAlD
Olanzapine—ADRA2A—telencephalon—Alzheimer's disease	0.000231	0.00288	CbGeAlD
Olanzapine—CHRM2—central nervous system—Alzheimer's disease	0.000231	0.00288	CbGeAlD
Olanzapine—H1F0—brain—Alzheimer's disease	0.000231	0.00287	CbGeAlD
Olanzapine—DRD1—brain—Alzheimer's disease	0.000228	0.00284	CbGeAlD
Olanzapine—HTR1D—central nervous system—Alzheimer's disease	0.000225	0.0028	CbGeAlD
Olanzapine—HTR2C—central nervous system—Alzheimer's disease	0.000223	0.00278	CbGeAlD
Olanzapine—HTR3A—brain—Alzheimer's disease	0.00022	0.00274	CbGeAlD
Olanzapine—CHRM1—nervous system—Alzheimer's disease	0.000219	0.00272	CbGeAlD
Olanzapine—HTR2B—nervous system—Alzheimer's disease	0.000217	0.00271	CbGeAlD
Olanzapine—HTR2A—forebrain—Alzheimer's disease	0.000214	0.00266	CbGeAlD
Olanzapine—CHRM1—central nervous system—Alzheimer's disease	0.00021	0.00262	CbGeAlD
Olanzapine—HTR2B—central nervous system—Alzheimer's disease	0.000209	0.00261	CbGeAlD
Olanzapine—HTR2A—telencephalon—Alzheimer's disease	0.000197	0.00245	CbGeAlD
Olanzapine—Amoxapine—SLC6A4—Alzheimer's disease	0.000196	0.0699	CrCbGaD
Olanzapine—CHRM3—nervous system—Alzheimer's disease	0.000196	0.00244	CbGeAlD
Olanzapine—CYP2D6—forebrain—Alzheimer's disease	0.000195	0.00243	CbGeAlD
Olanzapine—HTR1A—nervous system—Alzheimer's disease	0.000195	0.00243	CbGeAlD
Olanzapine—CHRM3—central nervous system—Alzheimer's disease	0.000188	0.00235	CbGeAlD
Olanzapine—HTR1A—central nervous system—Alzheimer's disease	0.000188	0.00234	CbGeAlD
Olanzapine—HTR7—nervous system—Alzheimer's disease	0.000186	0.00232	CbGeAlD
Olanzapine—HTR1B—brain—Alzheimer's disease	0.000185	0.0023	CbGeAlD
Olanzapine—CHRM2—brain—Alzheimer's disease	0.000184	0.00229	CbGeAlD
Olanzapine—HTR1A—cerebellum—Alzheimer's disease	0.000183	0.00228	CbGeAlD
Olanzapine—ADRA1A—nervous system—Alzheimer's disease	0.00018	0.00224	CbGeAlD
Olanzapine—HTR7—central nervous system—Alzheimer's disease	0.000179	0.00223	CbGeAlD
Olanzapine—CYP2D6—telencephalon—Alzheimer's disease	0.000179	0.00223	CbGeAlD
Olanzapine—HTR1D—brain—Alzheimer's disease	0.000179	0.00223	CbGeAlD
Olanzapine—HTR2C—brain—Alzheimer's disease	0.000177	0.0022	CbGeAlD
Olanzapine—DRD2—nervous system—Alzheimer's disease	0.000176	0.00219	CbGeAlD
Olanzapine—HTR7—cerebellum—Alzheimer's disease	0.000175	0.00218	CbGeAlD
Olanzapine—ADRA1A—central nervous system—Alzheimer's disease	0.000173	0.00215	CbGeAlD
Olanzapine—ALB—brain—Alzheimer's disease	0.000173	0.00215	CbGeAlD
Olanzapine—ADRA2C—nervous system—Alzheimer's disease	0.000171	0.00213	CbGeAlD
Olanzapine—DRD2—central nervous system—Alzheimer's disease	0.00017	0.00211	CbGeAlD
Olanzapine—ADRA1A—cerebellum—Alzheimer's disease	0.000169	0.0021	CbGeAlD
Olanzapine—CHRM1—brain—Alzheimer's disease	0.000167	0.00208	CbGeAlD
Olanzapine—HTR2B—brain—Alzheimer's disease	0.000166	0.00207	CbGeAlD
Olanzapine—DRD2—cerebellum—Alzheimer's disease	0.000166	0.00206	CbGeAlD
Olanzapine—ADRA2C—central nervous system—Alzheimer's disease	0.000165	0.00205	CbGeAlD
Olanzapine—ADRA2C—cerebellum—Alzheimer's disease	0.000161	0.00201	CbGeAlD
Olanzapine—ABCB1—embryo—Alzheimer's disease	0.000159	0.00197	CbGeAlD
Olanzapine—Loxapine—SLC6A4—Alzheimer's disease	0.000153	0.0546	CrCbGaD
Olanzapine—Amoxapine—HTR2A—Alzheimer's disease	0.000151	0.0538	CrCbGaD
Olanzapine—CHRM3—brain—Alzheimer's disease	0.00015	0.00186	CbGeAlD
Olanzapine—HTR1A—brain—Alzheimer's disease	0.000149	0.00185	CbGeAlD
Olanzapine—HTR7—brain—Alzheimer's disease	0.000142	0.00177	CbGeAlD
Olanzapine—ABCB1—forebrain—Alzheimer's disease	0.00014	0.00175	CbGeAlD
Olanzapine—HRH1—nervous system—Alzheimer's disease	0.000139	0.00173	CbGeAlD
Olanzapine—Amoxapine—CYP2D6—Alzheimer's disease	0.000138	0.0492	CrCbGaD
Olanzapine—ADRA1A—brain—Alzheimer's disease	0.000137	0.00171	CbGeAlD
Olanzapine—ADRA2A—nervous system—Alzheimer's disease	0.000137	0.0017	CbGeAlD
Olanzapine—DRD2—brain—Alzheimer's disease	0.000135	0.00168	CbGeAlD
Olanzapine—HRH1—central nervous system—Alzheimer's disease	0.000134	0.00167	CbGeAlD
Olanzapine—ADRA2A—central nervous system—Alzheimer's disease	0.000131	0.00164	CbGeAlD
Olanzapine—ADRA2C—brain—Alzheimer's disease	0.000131	0.00163	CbGeAlD
Olanzapine—ABCB1—telencephalon—Alzheimer's disease	0.000129	0.00161	CbGeAlD
Olanzapine—ADRA2A—cerebellum—Alzheimer's disease	0.000129	0.0016	CbGeAlD
Olanzapine—Loxapine—HTR2A—Alzheimer's disease	0.000118	0.042	CrCbGaD
Olanzapine—HTR2A—nervous system—Alzheimer's disease	0.000116	0.00145	CbGeAlD
Olanzapine—Quetiapine—HTR2A—Alzheimer's disease	0.000115	0.041	CrCbGaD
Olanzapine—HTR2A—central nervous system—Alzheimer's disease	0.000112	0.00139	CbGeAlD
Olanzapine—HTR2A—cerebellum—Alzheimer's disease	0.000109	0.00136	CbGeAlD
Olanzapine—CYP3A4—nervous system—Alzheimer's disease	0.000108	0.00134	CbGeAlD
Olanzapine—HRH1—brain—Alzheimer's disease	0.000106	0.00132	CbGeAlD
Olanzapine—CYP2D6—nervous system—Alzheimer's disease	0.000106	0.00132	CbGeAlD
Olanzapine—Quetiapine—CYP2D6—Alzheimer's disease	0.000105	0.0375	CrCbGaD
Olanzapine—ADRA2A—brain—Alzheimer's disease	0.000104	0.0013	CbGeAlD
Olanzapine—CYP3A4—central nervous system—Alzheimer's disease	0.000104	0.00129	CbGeAlD
Olanzapine—CYP2D6—central nervous system—Alzheimer's disease	0.000102	0.00127	CbGeAlD
Olanzapine—CYP2D6—cerebellum—Alzheimer's disease	9.96e-05	0.00124	CbGeAlD
Olanzapine—Clozapine—HTR2A—Alzheimer's disease	9.9e-05	0.0352	CrCbGaD
Olanzapine—Clozapine—CYP2D6—Alzheimer's disease	9.05e-05	0.0322	CrCbGaD
Olanzapine—HTR2A—brain—Alzheimer's disease	8.88e-05	0.00111	CbGeAlD
Olanzapine—CYP2D6—brain—Alzheimer's disease	8.09e-05	0.00101	CbGeAlD
Olanzapine—ABCB1—nervous system—Alzheimer's disease	7.61e-05	0.000948	CbGeAlD
Olanzapine—ABCB1—central nervous system—Alzheimer's disease	7.33e-05	0.000912	CbGeAlD
Olanzapine—ABCB1—cerebellum—Alzheimer's disease	7.16e-05	0.000892	CbGeAlD
Olanzapine—ABCB1—brain—Alzheimer's disease	5.82e-05	0.000724	CbGeAlD
Olanzapine—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.77e-06	1.66e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.76e-06	1.65e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.76e-06	1.65e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.75e-06	1.64e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	1.75e-06	1.64e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.75e-06	1.64e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.75e-06	1.64e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—IL6—Alzheimer's disease	1.75e-06	1.64e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.74e-06	1.63e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—IL6—Alzheimer's disease	1.74e-06	1.63e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.74e-06	1.63e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.74e-06	1.63e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.73e-06	1.62e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—APOE—Alzheimer's disease	1.73e-06	1.62e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.73e-06	1.62e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.72e-06	1.61e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PPARG—Alzheimer's disease	1.72e-06	1.61e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.72e-06	1.61e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.71e-06	1.61e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.71e-06	1.61e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.71e-06	1.61e-05	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.71e-06	1.6e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	1.71e-06	1.6e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.7e-06	1.6e-05	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.7e-06	1.59e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.69e-06	1.59e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.69e-06	1.58e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—INS—Alzheimer's disease	1.69e-06	1.58e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.69e-06	1.58e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.68e-06	1.58e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.68e-06	1.58e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.68e-06	1.57e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—AKT1—Alzheimer's disease	1.68e-06	1.57e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.67e-06	1.57e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.67e-06	1.57e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.67e-06	1.57e-05	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.65e-06	1.55e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.65e-06	1.54e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.65e-06	1.54e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.64e-06	1.53e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.64e-06	1.53e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.63e-06	1.53e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.63e-06	1.53e-05	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.63e-06	1.52e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.63e-06	1.52e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.62e-06	1.52e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.62e-06	1.52e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.62e-06	1.51e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.62e-06	1.51e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—AKT1—Alzheimer's disease	1.61e-06	1.51e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.61e-06	1.51e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.61e-06	1.51e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.61e-06	1.51e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.61e-06	1.51e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	1.6e-06	1.5e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.6e-06	1.5e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.6e-06	1.5e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.57e-06	1.47e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.56e-06	1.46e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.55e-06	1.45e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.55e-06	1.45e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.54e-06	1.45e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.54e-06	1.45e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.53e-06	1.44e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—INS—Alzheimer's disease	1.51e-06	1.42e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.51e-06	1.42e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.51e-06	1.41e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.51e-06	1.41e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.5e-06	1.41e-05	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.5e-06	1.41e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.49e-06	1.39e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.49e-06	1.39e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.48e-06	1.39e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.48e-06	1.39e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—NOS3—Alzheimer's disease	1.48e-06	1.39e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—INS—Alzheimer's disease	1.48e-06	1.38e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.48e-06	1.38e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.48e-06	1.38e-05	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.48e-06	1.38e-05	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.47e-06	1.38e-05	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.47e-06	1.38e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.47e-06	1.37e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.47e-06	1.37e-05	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.46e-06	1.37e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-06	1.37e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-06	1.37e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.46e-06	1.36e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-06	1.36e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.45e-06	1.36e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.45e-06	1.36e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.45e-06	1.36e-05	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-06	1.36e-05	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-06	1.35e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.45e-06	1.35e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.44e-06	1.35e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.44e-06	1.35e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.44e-06	1.35e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.43e-06	1.34e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.43e-06	1.34e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.43e-06	1.34e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.43e-06	1.34e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.42e-06	1.33e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.42e-06	1.33e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.41e-06	1.32e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.4e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.4e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.39e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.39e-06	1.3e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.39e-06	1.3e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.39e-06	1.3e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.38e-06	1.3e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.38e-06	1.29e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—INS—Alzheimer's disease	1.38e-06	1.29e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.37e-06	1.28e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.37e-06	1.28e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.37e-06	1.28e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.37e-06	1.28e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.36e-06	1.28e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—Alzheimer's disease	1.35e-06	1.27e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-06	1.26e-05	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.34e-06	1.26e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.34e-06	1.26e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-06	1.26e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.34e-06	1.26e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.34e-06	1.26e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.34e-06	1.25e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.34e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.33e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.33e-06	1.25e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.33e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.33e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.33e-06	1.25e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.33e-06	1.24e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.33e-06	1.24e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.32e-06	1.24e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-06	1.24e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.32e-06	1.24e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.32e-06	1.23e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-06	1.23e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.31e-06	1.23e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.31e-06	1.23e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.3e-06	1.22e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.3e-06	1.21e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.28e-06	1.2e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.28e-06	1.2e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.27e-06	1.19e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.27e-06	1.19e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.26e-06	1.18e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.26e-06	1.18e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.26e-06	1.18e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.25e-06	1.17e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.24e-06	1.16e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.24e-06	1.16e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	1.16e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.23e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.23e-06	1.15e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.23e-06	1.15e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.23e-06	1.15e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.22e-06	1.15e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.22e-06	1.14e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.22e-06	1.14e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-06	1.14e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-06	1.14e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.21e-06	1.14e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.21e-06	1.14e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.21e-06	1.13e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.2e-06	1.13e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.2e-06	1.13e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.19e-06	1.11e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.18e-06	1.11e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.18e-06	1.11e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-06	1.09e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.16e-06	1.08e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.16e-06	1.08e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.15e-06	1.07e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.14e-06	1.07e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-06	1.07e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-06	1.07e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-06	1.06e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.13e-06	1.06e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-06	1.06e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.13e-06	1.06e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.12e-06	1.05e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.12e-06	1.05e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-06	1.05e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.12e-06	1.05e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-06	1.05e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	1.04e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.09e-06	1.02e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.08e-06	1.01e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.07e-06	1e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.07e-06	9.99e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.07e-06	9.99e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.06e-06	9.94e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.06e-06	9.9e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-06	9.86e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.05e-06	9.84e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.04e-06	9.71e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.03e-06	9.7e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.03e-06	9.69e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.03e-06	9.64e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.94e-07	9.31e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	9.89e-07	9.26e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	9.62e-07	9.01e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	9.53e-07	8.93e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	9.5e-07	8.9e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	9.47e-07	8.87e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	9.46e-07	8.87e-06	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—Alzheimer's disease	9.39e-07	8.8e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	9.38e-07	8.79e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	9.36e-07	8.77e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	9.33e-07	8.74e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	9.3e-07	8.71e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	9.29e-07	8.7e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	9.21e-07	8.63e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	9.18e-07	8.6e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	9.17e-07	8.59e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	9.12e-07	8.54e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—INS—Alzheimer's disease	9.11e-07	8.53e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	8.87e-07	8.31e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	8.73e-07	8.18e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.73e-07	8.17e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	8.62e-07	8.07e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.59e-07	8.04e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	8.57e-07	8.03e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	8.54e-07	8e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	8.53e-07	7.99e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	8.51e-07	7.97e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	8.43e-07	7.9e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	8.41e-07	7.88e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	8.05e-07	7.54e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.99e-07	7.48e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.92e-07	7.42e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	7.9e-07	7.4e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	7.88e-07	7.38e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	7.85e-07	7.36e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	7.81e-07	7.32e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	7.78e-07	7.29e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	7.76e-07	7.27e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.31e-07	6.84e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	7.21e-07	6.75e-06	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—Alzheimer's disease	6.8e-07	6.37e-06	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	6.11e-07	5.72e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.96e-07	5.58e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.62e-07	5.26e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.57e-07	5.22e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.76e-07	4.46e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.67e-07	3.44e-06	CbGpPWpGaD
